Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma
Clinical trial NCT01455103 · WITHDRAWN
Trial details
- NCT number
- NCT01455103
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-11-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.